par Critchfield, J W;Ho, O;Roberts, Mary;Van Lint, Carine ;Verdin, Eric ;Butera, S T
Référence Antiviral chemistry & chemotherapy, 10, 5, page (275-284)
Publication Publié, 1999
Référence Antiviral chemistry & chemotherapy, 10, 5, page (275-284)
Publication Publié, 1999
Article révisé par les pairs
Titre: |
|
Auteur: | Critchfield, J W; Ho, O; Roberts, Mary; Van Lint, Carine; Verdin, Eric; Butera, S T |
Informations sur la publication: | Antiviral chemistry & chemotherapy, 10, 5, page (275-284) |
Statut de publication: | Publié, 1999 |
Sujet CREF: | Sciences bio-médicales et agricoles |
MeSH keywords: | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine -- pharmacology |
Anti-HIV Agents -- pharmacology | |
Chromatin -- genetics | |
Chromatin -- physiology | |
Enzyme Inhibitors -- pharmacology | |
HIV Infections -- drug therapy | |
HIV Infections -- virology | |
HIV-1 -- drug effects | |
HIV-1 -- genetics | |
HIV-1 -- growth & development | |
HIV-1 -- physiology | |
HL-60 Cells -- metabolism | |
HL-60 Cells -- virology | |
Humans | |
Isoquinolines -- pharmacology | |
NF-kappa B -- antagonists & inhibitors | |
NF-kappa B -- physiology | |
Protein Kinase Inhibitors | |
RNA, Viral -- drug effects | |
RNA, Viral -- genetics | |
Sulfonamides -- pharmacology | |
Transcription, Genetic -- drug effects | |
Tumor Necrosis Factor-alpha -- pharmacology | |
Virus Activation -- drug effects | |
Virus Activation -- genetics | |
Virus Latency -- drug effects | |
Virus Latency -- genetics | |
Note générale: | Journal Article |
Research Support, Non-U.S. Gov't | |
SCOPUS: ar.j | |
Langue: | Anglais |
Identificateurs: | urn:issn:0956-3202 |
info:scp/0032843282 | |
info:pmid/10574182 |